Published in World J Gastroenterol on January 01, 2003
Assessment of the age-specific disability weight of chronic schistosomiasis japonica. Bull World Health Organ (2007) 1.70
Ginkgo biloba extract reverses CCl4-induced liver fibrosis in rats. World J Gastroenterol (2004) 1.22
c-Jun N-terminal kinase is required for vitamin E succinate-induced apoptosis in human gastric cancer cells. World J Gastroenterol (2004) 0.80
Therapeutic effect of alpha lipoic acid combined with praziquantel on liver fibrosis induced by Schistosoma mansoni challenged mice. Parasitol Res (2012) 0.79
Gene-expression analysis of single cells-nested polymerase chain reaction after laser microdissection. World J Gastroenterol (2003) 0.78
Effect of ketoconazole, a cytochrome P450 inhibitor, on the efficacy of quinine and halofantrine against Schistosoma mansoni in mice. Korean J Parasitol (2013) 0.75
Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis (2001) 2.98
Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol (2001) 2.95
Activation of hepatic stellate cells--a key issue in liver fibrosis. Front Biosci (2002) 2.49
Hepatic stellate cells: a target for the treatment of liver fibrosis. J Gastroenterol (2000) 1.72
Chronic liver injury, TGF-beta, and cancer. Exp Mol Med (2001) 1.65
Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology (2002) 1.62
Transforming growth factor beta1 induces the expression of alpha1(I) procollagen mRNA by a hydrogen peroxide-C/EBPbeta-dependent mechanism in rat hepatic stellate cells. Hepatology (1999) 1.62
Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-beta soluble receptor: implications for antifibrotic therapy. Hepatology (2002) 1.52
Dynamic changes of type I,III and IV collagen synthesis and distribution of collagen-producing cells in carbon tetrachloride-induced rat liver fibrosis. World J Gastroenterol (1999) 1.47
Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-beta. Gastroenterology (2001) 1.32
Advances in gene therapy of liver cirrhosis: a review. World J Gastroenterol (2001) 1.30
Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis. Gut (2002) 1.29
Pharmacological aspects of pentoxifylline with emphasis on its inhibitory actions on hepatic fibrogenesis. Gen Pharmacol (1997) 1.28
Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-beta. J Viral Hepat (2001) 1.23
Cytokine regulation of hepatic stellate cells in liver fibrosis. Alcohol Clin Exp Res (1999) 1.17
Matrix metalloproteinase-2 activation in human hepatic fibrosis regulation by cell-matrix interactions. Hepatology (1999) 1.06
Expression and matrix deposition of latent transforming growth factor beta binding proteins in normal and fibrotic rat liver and transdifferentiating hepatic stellate cells in culture. Hepatology (2001) 1.06
Quantitative analysis of transforming growth factor beta 1 mRNA in patients with alcoholic liver disease. World J Gastroenterol (2002) 1.06
Targeting hepatic stellate cells for cell-specific treatment of liver fibrosis. Front Biosci (2002) 1.02
Effect of pentoxifylline on early proliferation and phenotypic modulation of fibrogenic cells in two rat models of liver fibrosis and on cultured hepatic stellate cells. J Hepatol (1999) 1.00
Reversibility of hepatic fibrosis: from the first report of collagenase in the liver to the possibility of gene therapy for recovery. Keio J Med (2001) 0.98
Expression of exogenous rat collagenase in vitro and in a rat model of liver fibrosis. World J Gastroenterol (2002) 0.94
Fibrosis of liver, pancreas and intestine: common mechanisms and clear targets? Acta Gastroenterol Belg (2001) 0.86
Pentoxifylline inhibits growth and collagen synthesis of cultured human hepatic myofibroblast-like cells. Hepatology (1997) 0.85
Quantitative and qualitative interferences of pentoxifillyne on hepatic Schistosoma mansoni granulomas: effects on extracellular matrix and eosinophil population. Mem Inst Oswaldo Cruz (2001) 0.82
Effect of preoperative interventions on outcome following liver resection in a rat model of cirrhosis. J Hepatol (2000) 0.81
Characteristics of the cell proliferation profile of activated rat hepatic stellate cells in vitro in contrast to their fibrogenesis activity. J Gastroenterol (2001) 0.79
Intestinal flora translocation and overgrowth in upper gastrointestinal tract induced by hepatic failure. World J Gastroenterol (1999) 0.86
The CD226 gene in susceptibility of rheumatoid arthritis in the Chinese Han population. Rheumatol Int (2011) 0.79
[Gene (SCN5A) mutation analysis of a Chinese family with Brugada syndrome]. Zhonghua Xin Xue Guan Bing Za Zhi (2007) 0.79
Analysis of prognosis on patients with severe viral hepatitis using the model for end-stage liver disease. World J Gastroenterol (2005) 0.78
Differentiation of hepatocytoid cell induced from whole-bone-marrow method isolated rat myeloid mesenchymal stem cells. World J Gastroenterol (2006) 0.78
[Effects of intrauterine growth restriction and high-fat diet on serum lipid and transcriptional levels of related hepatic genes in rats]. Zhongguo Dang Dai Er Ke Za Zhi (2015) 0.76
Replication of clinical hepatitis B virus isolate and its application for selecting antiviral agents for chronic hepatitis B patients. World J Gastroenterol (2008) 0.75
[Analysis of prognosis on patients with severe viral hepatitis using the model for end-stage liver disease]. Zhonghua Gan Zang Bing Za Zhi (2005) 0.75
Promoting hepatic growth factor in the treatment of heavy type hepatitis and severe chronic hepatitis: a multicenter clinical study. Hepatobiliary Pancreat Dis Int (2004) 0.75
[Gene mutation in secundum atrial septal defect: analysis of a Chinese family with 3 patients]. Zhonghua Yi Xue Za Zhi (2008) 0.75